febuxostat has been researched along with chrysin in 1 studies
Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (chrysin) | Trials (chrysin) | Recent Studies (post-2010) (chrysin) |
---|---|---|---|---|---|
818 | 133 | 710 | 913 | 6 | 646 |
Protein | Taxonomy | febuxostat (IC50) | chrysin (IC50) |
---|---|---|---|
G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 7.1 | |
Cytochrome P450 1A1 | Homo sapiens (human) | 0.7215 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.236 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 7.1 | |
Aromatase | Homo sapiens (human) | 0.667 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 5.225 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 7.1 | |
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.14 | |
G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 5.85 | |
Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 7.79 | |
Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | 0.67 | |
Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | 5.85 | |
Casein kinase II subunit alpha' | Homo sapiens (human) | 9 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.6 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 1.6 | |
Proteasome subunit beta type-5 | Homo sapiens (human) | 5.5 | |
Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 0.84 | |
Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 7.2 | |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | 7.2 | |
Casein kinase II subunit beta | Homo sapiens (human) | 9 | |
Casein kinase II subunit alpha | Homo sapiens (human) | 9 | |
Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | 1.26 | |
Cyclin-dependent kinase 6 | Homo sapiens (human) | 5.88 | |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 5.3 | |
Cyclin homolog | Herpesvirus saimiri (strain 11) | 5.85 | |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 5.3 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 0.152 | |
Integrase | Human immunodeficiency virus 1 | 1.4 | |
Casein kinase II subunit alpha 3 | Homo sapiens (human) | 9 | |
G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 7.1 | |
3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 10 | |
Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 5.85 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 2.05 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderluh, M; Jakopin, Ž; Kocić, G; Petronijević, Ž; Šmelcerović, A; Šmelcerović, Ž; Tomašič, T; Tomović, K | 1 |
1 review(s) available for febuxostat and chrysin
Article | Year |
---|---|
Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
Topics: Allopurinol; Computer Simulation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Febuxostat; Humans; Molecular Structure; Structure-Activity Relationship; Xanthine Oxidase | 2017 |